This bill would amend the Federal Food, Drug, and Cosmetic Act to prohibit intentionally added perfluoroalkyl and polyfluoroalkyl substances, often called PFAS, in cosmetic products. It would mainly affect cosmetic manufacturers, importers, and retailers that sell makeup, skincare, hair products, and related personal-care items. The bill is aimed at reducing consumers’ exposure to long-lasting chemicals that can remain in the body and the environment.
What This Bill Does
- Bans intentionally added PFAS in cosmetics
- Applies through the Federal Food, Drug, and Cosmetic Act
- Targets cosmetic products sold in the U.S. market
- Would require manufacturers to reformulate affected products
Who This Bill Affects
For most people, this would not change what they can buy right away, but it could affect the cosmetics they see on store shelves over time. If the bill becomes law, products sold in the U.S. would need to avoid intentionally added PFAS, which could lead to ingredient changes in some long-wear, waterproof, or stain-resistant cosmetics. Consumers who use those products could benefit from lower exposure to persistent chemicals, while prices or product availability could shift if companies need to reformulate.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- Public-health advocates They argue cosmetics should not contain intentionally added PFAS because these chemicals are persistent and can expose users through daily, repeated contact. A federal ban would reduce a source of avoidable chemical exposure.
- Consumers who use cosmetics regularly They want safer products with fewer hard-to-detect ingredients of concern. A clear national prohibition would make it easier to choose products without relying on state-by-state standards or incomplete labeling.
- Environmental health researchers They support reducing PFAS at the source because these compounds can move from consumer products into wastewater and the broader environment. Limiting them in cosmetics can also encourage safer product design.
- Cosmetic manufacturers They may argue the rule would force costly reformulation and testing, especially for products that depend on PFAS for water resistance, texture, or wear time. Some companies could also face disruptions in supply chains and product lines.
- Retailers and importers of beauty products They may worry about compliance burdens and the possibility that products already on the market would need to be withdrawn or relabeled. That can create inventory losses and administrative costs.
- Ingredient suppliers They could object that the ban reduces demand for certain specialty ingredients before replacement materials are fully validated. They may also argue that some PFAS uses are more functional than harmful in cosmetics and should be handled through narrower rules.
Key Implications
-
““ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics””
This would prohibit cosmetic products from using PFAS on purpose as ingredients or functional additives. Brands that currently use these chemicals would need to change formulas to keep selling those products in the U.S.
-
““amend the Federal Food, Drug, and Cosmetic Act””
The ban would be enforced through federal cosmetics law, giving regulators a nationwide standard. That matters because it would apply broadly across states instead of leaving consumers and companies with different rules in different places.
-
““for other purposes””
This language typically allows related implementation steps, such as enforcement or conforming updates. In practice, that can affect how quickly agencies and companies have to adjust to the new prohibition.
Official Source & Bill Facts
BillBoard checks this page against public Congress.gov metadata, then adds plain-English analysis where available.
- Bill
- HR 9594
- Congress
- 119th Congress
- Official title
- To amend the Federal Food, Drug, and Cosmetic Act to ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics, and for other purposes.
- Policy area
- Healthcare
- Latest action
- Referred to the House Committee on Energy and Commerce. (July 6, 2026)
- Last updated
- July 7, 2026
Latest Status
July 6, 2026
Referred to the House Committee on Energy and Commerce.
Related Bills
Browse more Healthcare bills in Congress →
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.